Melbourne, Australia:  Starpharma (ASX: SPL; OCTQX: SPHRY) today released its Appendix 4C - Quarterly Cashflow report for the period ended 31 March 2012.

The cash balance at 31 March 2012 was $46.6m.  Total operating and investing cash outflow for the quarter was $2.2m.

Read more